![]() |
||||||
|
![]() | Fusion Gene Summary |
![]() | Fusion Gene ORF analysis |
![]() | Fusion Genomic Features |
![]() | Fusion Protein Features |
![]() | Fusion Gene Sequence |
![]() | Fusion Gene PPI analysis |
![]() | Related Drugs |
![]() | Related Diseases |
Fusion gene:CD83-LAMA2 (FusionGDB2 ID:HG9308TG3908) |
Fusion Gene Summary for CD83-LAMA2 |
![]() |
Fusion gene information | Fusion gene name: CD83-LAMA2 | Fusion gene ID: hg9308tg3908 | Hgene | Tgene | Gene symbol | CD83 | LAMA2 | Gene ID | 9308 | 3908 |
Gene name | CD83 molecule | laminin subunit alpha 2 | |
Synonyms | BL11|HB15 | LAMM|MDC1A | |
Cytomap | ('CD83')('LAMA2') 6p23 | 6q22.33 | |
Type of gene | protein-coding | protein-coding | |
Description | CD83 antigenB-cell activation proteinCD83 antigen (activated B lymphocytes, immunoglobulin superfamily)cell surface protein HB15cell-surface glycoproteinhCD83 | laminin subunit alpha-2laminin M chainlaminin, alpha 2laminin-12 subunit alphalaminin-2 subunit alphalaminin-4 subunit alphamerosin heavy chainmutant laminin subunit alpha 2 | |
Modification date | 20200313 | 20200328 | |
UniProtAcc | Q01151 | . | |
Ensembl transtripts involved in fusion gene | ENST00000379153, | ||
Fusion gene scores | * DoF score | 4 X 4 X 4=64 | 16 X 17 X 7=1904 |
# samples | 4 | 17 | |
** MAII score | log2(4/64*10)=-0.678071905112638 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(17/1904*10)=-3.48542682717024 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: CD83 [Title/Abstract] AND LAMA2 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | CD83(14118296)-LAMA2(129663488), # samples:3 | ||
Anticipated loss of major functional domain due to fusion event. | CD83-LAMA2 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. CD83-LAMA2 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. CD83-LAMA2 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. CD83-LAMA2 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | BRCA | TCGA-BH-A1FD-01A | CD83 | chr6 | 14118296 | - | LAMA2 | chr6 | 129663488 | + |
ChimerDB4 | BRCA | TCGA-BH-A1FD-01A | CD83 | chr6 | 14118296 | + | LAMA2 | chr6 | 129663488 | + |
Top |
Fusion Gene ORF analysis for CD83-LAMA2 |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-intron | ENST00000379153 | ENST00000498257 | CD83 | chr6 | 14118296 | + | LAMA2 | chr6 | 129663488 | + |
In-frame | ENST00000379153 | ENST00000421865 | CD83 | chr6 | 14118296 | + | LAMA2 | chr6 | 129663488 | + |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000379153 | CD83 | chr6 | 14118296 | + | ENST00000421865 | LAMA2 | chr6 | 129663488 | + | 5604 | 324 | 171 | 5381 | 1736 |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000379153 | ENST00000421865 | CD83 | chr6 | 14118296 | + | LAMA2 | chr6 | 129663488 | + | 0.000757063 | 0.9992429 |
Top |
Fusion Genomic Features for CD83-LAMA2 |
![]() |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
CD83 | chr6 | 14118296 | + | LAMA2 | chr6 | 129663487 | + | 1.31E-07 | 0.9999999 |
CD83 | chr6 | 14118296 | + | LAMA2 | chr6 | 129663487 | + | 1.31E-07 | 0.9999999 |
![]() |
![]() |
![]() |
![]() |
Top |
Fusion Protein Features for CD83-LAMA2 |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr6:14118296/chr6:129663488) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
CD83 | . |
FUNCTION: May play a significant role in antigen presentation or the cellular interactions that follow lymphocyte activation. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | LAMA2 | chr6:14118296 | chr6:129663488 | ENST00000421865 | 28 | 65 | 1630_2150 | 1437 | 3123.0 | Coiled coil | Ontology_term=ECO:0000255 | |
Tgene | LAMA2 | chr6:14118296 | chr6:129663488 | ENST00000421865 | 28 | 65 | 1469_1526 | 1437 | 3123.0 | Domain | Laminin EGF-like 16 | |
Tgene | LAMA2 | chr6:14118296 | chr6:129663488 | ENST00000421865 | 28 | 65 | 1527_1573 | 1437 | 3123.0 | Domain | Laminin EGF-like 17 | |
Tgene | LAMA2 | chr6:14118296 | chr6:129663488 | ENST00000421865 | 28 | 65 | 2145_2328 | 1437 | 3123.0 | Domain | Laminin G-like 1 | |
Tgene | LAMA2 | chr6:14118296 | chr6:129663488 | ENST00000421865 | 28 | 65 | 2340_2521 | 1437 | 3123.0 | Domain | Laminin G-like 2 | |
Tgene | LAMA2 | chr6:14118296 | chr6:129663488 | ENST00000421865 | 28 | 65 | 2526_2710 | 1437 | 3123.0 | Domain | Laminin G-like 3 | |
Tgene | LAMA2 | chr6:14118296 | chr6:129663488 | ENST00000421865 | 28 | 65 | 2763_2934 | 1437 | 3123.0 | Domain | Laminin G-like 4 | |
Tgene | LAMA2 | chr6:14118296 | chr6:129663488 | ENST00000421865 | 28 | 65 | 2939_3110 | 1437 | 3123.0 | Domain | Laminin G-like 5 | |
Tgene | LAMA2 | chr6:14118296 | chr6:129663488 | ENST00000421865 | 28 | 65 | 1574_2144 | 1437 | 3123.0 | Region | Note=Domain II and I |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | CD83 | chr6:14118296 | chr6:129663488 | ENST00000379153 | + | 2 | 5 | 20_114 | 51 | 206.0 | Domain | Note=Ig-like V-type |
Hgene | CD83 | chr6:14118296 | chr6:129663488 | ENST00000379153 | + | 2 | 5 | 167_205 | 51 | 206.0 | Topological domain | Cytoplasmic |
Hgene | CD83 | chr6:14118296 | chr6:129663488 | ENST00000379153 | + | 2 | 5 | 20_144 | 51 | 206.0 | Topological domain | Extracellular |
Hgene | CD83 | chr6:14118296 | chr6:129663488 | ENST00000379153 | + | 2 | 5 | 145_166 | 51 | 206.0 | Transmembrane | Helical |
Tgene | LAMA2 | chr6:14118296 | chr6:129663488 | ENST00000421865 | 28 | 65 | 1014_1059 | 1437 | 3123.0 | Domain | Laminin EGF-like 11 | |
Tgene | LAMA2 | chr6:14118296 | chr6:129663488 | ENST00000421865 | 28 | 65 | 1060_1105 | 1437 | 3123.0 | Domain | Laminin EGF-like 12 | |
Tgene | LAMA2 | chr6:14118296 | chr6:129663488 | ENST00000421865 | 28 | 65 | 1106_1165 | 1437 | 3123.0 | Domain | Laminin EGF-like 13 | |
Tgene | LAMA2 | chr6:14118296 | chr6:129663488 | ENST00000421865 | 28 | 65 | 1166_1175 | 1437 | 3123.0 | Domain | Laminin EGF-like 14%3B first part | |
Tgene | LAMA2 | chr6:14118296 | chr6:129663488 | ENST00000421865 | 28 | 65 | 1176_1379 | 1437 | 3123.0 | Domain | Laminin IV type A 2 | |
Tgene | LAMA2 | chr6:14118296 | chr6:129663488 | ENST00000421865 | 28 | 65 | 1380_1419 | 1437 | 3123.0 | Domain | Laminin EGF-like 14%3B second part | |
Tgene | LAMA2 | chr6:14118296 | chr6:129663488 | ENST00000421865 | 28 | 65 | 1420_1468 | 1437 | 3123.0 | Domain | Laminin EGF-like 15 | |
Tgene | LAMA2 | chr6:14118296 | chr6:129663488 | ENST00000421865 | 28 | 65 | 287_343 | 1437 | 3123.0 | Domain | Laminin EGF-like 1 | |
Tgene | LAMA2 | chr6:14118296 | chr6:129663488 | ENST00000421865 | 28 | 65 | 344_413 | 1437 | 3123.0 | Domain | Laminin EGF-like 2 | |
Tgene | LAMA2 | chr6:14118296 | chr6:129663488 | ENST00000421865 | 28 | 65 | 35_286 | 1437 | 3123.0 | Domain | Laminin N-terminal | |
Tgene | LAMA2 | chr6:14118296 | chr6:129663488 | ENST00000421865 | 28 | 65 | 414_468 | 1437 | 3123.0 | Domain | Laminin EGF-like 3 | |
Tgene | LAMA2 | chr6:14118296 | chr6:129663488 | ENST00000421865 | 28 | 65 | 469_517 | 1437 | 3123.0 | Domain | Laminin EGF-like 4 | |
Tgene | LAMA2 | chr6:14118296 | chr6:129663488 | ENST00000421865 | 28 | 65 | 518_527 | 1437 | 3123.0 | Domain | Laminin EGF-like 5%3B first part | |
Tgene | LAMA2 | chr6:14118296 | chr6:129663488 | ENST00000421865 | 28 | 65 | 531_723 | 1437 | 3123.0 | Domain | Laminin IV type A 1 | |
Tgene | LAMA2 | chr6:14118296 | chr6:129663488 | ENST00000421865 | 28 | 65 | 724_756 | 1437 | 3123.0 | Domain | Laminin EGF-like 5%3B second part | |
Tgene | LAMA2 | chr6:14118296 | chr6:129663488 | ENST00000421865 | 28 | 65 | 757_806 | 1437 | 3123.0 | Domain | Laminin EGF-like 6 | |
Tgene | LAMA2 | chr6:14118296 | chr6:129663488 | ENST00000421865 | 28 | 65 | 807_864 | 1437 | 3123.0 | Domain | Laminin EGF-like 7 | |
Tgene | LAMA2 | chr6:14118296 | chr6:129663488 | ENST00000421865 | 28 | 65 | 865_917 | 1437 | 3123.0 | Domain | Laminin EGF-like 8 | |
Tgene | LAMA2 | chr6:14118296 | chr6:129663488 | ENST00000421865 | 28 | 65 | 918_966 | 1437 | 3123.0 | Domain | Laminin EGF-like 9 | |
Tgene | LAMA2 | chr6:14118296 | chr6:129663488 | ENST00000421865 | 28 | 65 | 967_1013 | 1437 | 3123.0 | Domain | Laminin EGF-like 10 |
Top |
Fusion Gene Sequence for CD83-LAMA2 |
![]() |
>14699_14699_1_CD83-LAMA2_CD83_chr6_14118296_ENST00000379153_LAMA2_chr6_129663488_ENST00000421865_length(transcript)=5604nt_BP=324nt GCGCCCCGGCCTAAGCGGGACTAGGAGGGCGCGCCACCCGCTTCCGCTGCCCGCCGGGGAATCCCCCGGGCTGGCGCGCAGGGAAGTTCC CGAACGCGCGGGCATAAAAGGGCAGCCGGCGCCCGCGCGCCACAGCTCTGCAGCTCGTGGCAGCGGCGCAGCGCTCCAGCCATGTCGCGC GGCCTCCAGCTTCTGCTCCTGAGCTGCGCCTACAGCCTGGCTCCCGCGACGCCGGAGGTGAAGGTGGCTTGCTCCGAAGATGTGGACTTG CCCTGCACCGCCCCCTGGGATCCGCAGGTTCCCTACACGGTCTCCTGGGTCAAGAATTGTCAACATCACACTGCTGGTGACTTCTGTGAA CGATGTGCTCTTGGATACTATGGAATTGTCAAGGGATTGCCAAATGACTGTCAGCAATGTGCCTGCCCTCTGATTTCTTCCAGTAACAAT TTCAGCCCCTCTTGTGTCGCAGAAGGACTTGACGACTACCGCTGCACGGCTTGTCCACGGGGATATGAAGGCCAGTACTGTGAAAGGTGT GCCCCTGGCTATACTGGCAGTCCAGGCAACCCTGGAGGCTCCTGCCAAGAATGTGAGTGTGATCCCTATGGCTCACTGCCTGTGCCCTGT GACCCTGTCACAGGATTCTGCACGTGCCGACCTGGAGCCACGGGAAGGAAGTGTGACGGCTGCAAGCACTGGCATGCACGCGAGGGCTGG GAGTGTGTTTTTTGTGGAGATGAGTGCACTGGCCTTCTTCTCGGTGACTTGGCTCGCCTGGAGCAGATGGTCATGAGCATCAACCTCACT GGTCCGCTGCCTGCGCCATATAAAATGCTGTATGGTCTTGAAAATATGACTCAGGAGCTAAAGCACTTGCTGTCACCTCAGCGGGCCCCA GAGAGGCTTATTCAGCTGGCAGAGGGCAATCTGAATACACTCGTGACCGAAATGAACGAGCTGCTGACCAGGGCTACCAAAGTGACAGCA GATGGCGAGCAGACCGGACAGGATGCTGAGAGGACCAACACAAGAGCAAAGTCCCTGGGAGAATTCATTAAGGAGCTTGCCCGGGATGCA GAAGCTGTAAATGAAAAAGCTATAAAACTAAATGAAACTCTAGGAACTCGAGACGAGGCCTTTGAGAGAAATTTGGAAGGGCTTCAGAAA GAGATTGACCAGATGATTAAAGAACTGAGGAGGAAAAATCTAGAGACACAAAAGGAAATTGCTGAAGATGAGTTGGTAGCTGCAGAAGCC CTTCTGAAAAAAGTGAAGAAGCTGTTTGGAGAGTCCCGGGGGGAAAATGAAGAAATGGAGAAGGATCTCCGGGAAAAACTGGCTGACTAC AAAAACAAAGTTGATGATGCTTGGGACCTTTTGAGAGAAGCCACAGATAAAATCAGAGAAGCTAATCGCCTATTTGCAGTAAATCAGAAA AACATGACTGCATTGGAGAAAAAGAAGGAGGCTGTTGAAAGCGGCAAACGACAAATTGAGAACACTTTAAAAGAGGGCAATGACATACTC GATGAAGCCAACCGTCTTGCAGATGAAATCAACTCCATCATAGACTATGTTGAAGACATCCAAACTAAATTGCCACCTATGTCTGAGGAG CTTAATGATAAAATAGATGACCTCTCCCAAGAAATAAAGGACAGGAAGCTTGCTGAGAAGGTGTCCCAGGCTGAGAGCCACGCAGCTCAG TTGAATGACTCATCTGCTGTCCTTGATGGAATCCTTGATGAGGCTAAAAACATCTCCTTCAATGCCACTGCAGCCTTCAAAGCTTACAGC AATATTAAGGACTATATTGATGAAGCTGAGAAAGTTGCCAAAGAAGCCAAAGATCTTGCACATGAAGCTACAAAACTGGCAACAGGTCCT CGGGGTTTATTAAAGGAAGATGCCAAAGGCTGTCTTCAGAAAAGCTTCAGGATTCTTAACGAAGCCAAGAAGTTAGCAAATGATGTAAAA GAAAATGAAGACCATCTAAATGGCTTAAAAACCAGGATAGAAAATGCTGATGCTAGAAATGGGGATCTCTTGAGAACTTTGAATGACACT TTGGGAAAGTTATCAGCTATTCCAAATGATACAGCTGCTAAACTGCAAGCTGTTAAGGACAAAGCCAGACAAGCCAACGACACAGCTAAA GATGTACTGGCACAGATTACAGAGCTCCACCAGAACCTCGATGGCCTGAAGAAGAATTACAATAAACTAGCAGACAGCGTCGCCAAAACG AATGCTGTGGTTAAAGATCCTTCCAAGAACAAAATCATTGCCGATGCAGATGCCACTGTCAAAAATTTAGAACAGGAAGCTGACCGGCTA ATAGATAAACTCAAACCCATCAAGGAACTTGAGGATAACCTAAAGAAAAACATCTCTGAGATAAAGGAATTGATAAACCAAGCTCGGAAA CAAGCCAATTCTATCAAAGTATCTGTGTCTTCAGGAGGTGACTGCATTCGAACATACAAACCAGAAATCAAGAAAGGAAGTTACAATAAT ATTGTTGTCAACGTAAAGACAGCTGTTGCTGATAACCTCCTCTTTTATCTTGGAAGTGCCAAATTTATTGACTTTCTGGCTATAGAAATG CGTAAAGGCAAAGTCAGCTTCCTCTGGGATGTTGGATCTGGAGTTGGACGTGTAGAGTACCCAGATTTGACTATTGATGACTCATATTGG TACCGTATCGTAGCATCAAGAACTGGGAGAAATGGAACTATTTCTGTGAGAGCCCTGGATGGACCCAAAGCCAGCATTGTGCCCAGCACA CACCATTCGACGTCTCCTCCAGGGTACACGATTCTAGATGTGGATGCAAATGCAATGCTGTTTGTTGGTGGCCTGACTGGGAAATTAAAG AAGGCTGATGCTGTACGTGTGATTACATTCACTGGCTGCATGGGAGAAACATACTTTGACAACAAACCTATAGGTTTGTGGAATTTCCGA GAAAAAGAAGGTGACTGCAAAGGATGCACTGTCAGTCCTCAGGTGGAAGATAGTGAGGGGACTATTCAATTTGATGGAGAAGGTTATGCA TTGGTCAGCCGTCCCATTCGCTGGTACCCCAACATCTCCACTGTCATGTTCAAGTTCAGAACATTTTCTTCGAGTGCTCTTCTGATGTAT CTTGCCACACGAGACCTGAGAGATTTCATGAGTGTGGAGCTCACTGATGGGCACATAAAAGTCAGTTACGATCTGGGCTCAGGAATGGCT TCCGTTGTCAGCAATCAAAACCATAATGATGGGAAATGGAAATCATTCACTCTGTCAAGAATTCAAAAACAAGCCAATATATCAATTGTA GATATAGATACTAATCAGGAGGAGAATATAGCAACTTCGTCTTCTGGAAACAACTTTGGTCTTGACTTGAAAGCAGATGACAAAATATAT TTTGGTGGCCTGCCAACGCTGAGAAACTTGAGTATGAAAGCAAGGCCAGAAGTAAATCTGAAGAAATATTCCGGCTGCCTCAAAGATATT GAAATTTCAAGAACTCCGTACAATATACTCAGTAGTCCCGATTATGTTGGTGTTACCAAAGGATGTTCCCTGGAGAATGTTTACACAGTT AGCTTTCCTAAGCCTGGTTTTGTGGAGCTCTCCCCTGTGCCAATTGATGTAGGAACAGAAATCAACCTGTCATTCAGCACCAAGAATGAG TCCGGCATCATTCTTTTGGGAAGTGGAGGGACACCAGCACCACCTAGGAGAAAACGAAGGCAGACTGGACAGGCCTATTATGCAATACTC CTCAACAGGGGCCGTCTGGAAGTGCATCTCTCCACAGGGGCACGAACAATGAGGAAAATTGTGATCAGACCAGAGCCGAATCTGTTTCAT GATGGAAGAGAACATTCCGTTCATGTAGAGCGAACTAGAGGCATCTTTACAGTTCAAGTGGATGAAAACAGAAGATACATGCAAAACCTG ACAGTTGAACAGCCTATCGAAGTTAAAAAGCTTTTCGTTGGGGGTGCTCCACCTGAATTTCAACCTTCCCCACTCAGAAATATTCCTCCT TTTGAAGGCTGCATATGGAATCTTGTTATTAACTCTGTCCCCATGGACTTTGCAAGGCCTGTGTCCTTCAAAAATGCTGACATTGGTCGC TGTGCCCATCAGAAACTCCGTGAAGATGAAGATGGAGCAGCTCCAGCTGAAATAGTTATCCAGCCTGAGCCAGTTCCCACCCCAGCCTTT CCTACGCCCACCCCAGTTCTGACACATGGTCCTTGTGCTGCAGAATCAGAACCAGCTCTTTTGATAGGGAGCAAGCAGTTCGGGCTTTCA AGAAACAGTCACATTGCAATTGCATTTGATGACACCAAAGTTAAAAACCGTCTCACAATTGAGTTGGAAGTAAGAACCGAAGCTGAATCC GGCTTGCTTTTTTACATGGCTCGCATCAATCATGCTGATTTTGCAACAGTTCAGCTGAGAAATGGATTGCCCTACTTCAGCTATGACTTG GGGAGTGGGGACACCCACACCATGATCCCCACCAAAATCAATGATGGCCAGTGGCACAAGATTAAGATAATGAGAAGTAAGCAAGAAGGA ATTCTTTATGTAGATGGGGCTTCCAACAGAACCATCAGTCCCAAAAAAGCCGACATCCTGGATGTCGTGGGAATGCTGTATGTTGGTGGG TTACCCATCAACTACACTACCCGAAGAATTGGTCCAGTGACCTATAGCATTGATGGCTGCGTCAGGAATCTCCACATGGCAGAGGCCCCT GCCGATCTGGAACAACCCACCTCCAGCTTCCATGTTGGGACATGTTTTGCAAATGCTCAGAGGGGAACATATTTTGACGGAACCGGTTTT GCCAAAGCAGTTGGTGGATTCAAAGTGGGATTGGACCTTCTTGTAGAATTTGAATTCCGCACAACTACAACGACTGGAGTTCTTCTGGGG ATCAGTAGTCAAAAAATGGATGGAATGGGTATTGAAATGATTGATGAAAAGTTGATGTTTCATGTGGACAATGGTGCGGGCAGATTCACT GCTGTCTATGATGCTGGGGTTCCAGGGCATTTGTGTGATGGACAATGGCATAAAGTCACTGCCAACAAGATCAAACACCGCATTGAGCTC ACAGTCGATGGGAACCAGGTGGAAGCCCAAAGCCCAAACCCAGCATCTACATCAGCTGACACAAATGACCCTGTGTTTGTTGGAGGCTTC CCAGATGACCTCAAGCAGTTTGGCCTAACAACCAGTATTCCGTTCCGAGGTTGCATCAGATCCCTGAAGCTCACCAAAGGCACAGGCAAG CCACTGGAGGTTAATTTTGCCAAGGCCCTGGAACTGAGGGGCGTTCAACCTGTATCATGCCCAGCCAACTAATAAAAATAAGTGTAACCC CAGGAAGAGTCTGTCAAAACAAGTATATCAAGTAAAACAAACAAATATATTTTACCTATATATGTTAATTAAACTAATTTGTGCATGTAC ATAGAATTCTTTCTGTATTCAGATGGTGCTAATTCAGACTCCAGACTGAATTTTAATTCAAGTTCTTTCTCAAGTCTATAAATAATATTA >14699_14699_1_CD83-LAMA2_CD83_chr6_14118296_ENST00000379153_LAMA2_chr6_129663488_ENST00000421865_length(amino acids)=1736AA_BP=51 MSRGLQLLLLSCAYSLAPATPEVKVACSEDVDLPCTAPWDPQVPYTVSWVKNCQHHTAGDFCERCALGYYGIVKGLPNDCQQCACPLISS SNNFSPSCVAEGLDDYRCTACPRGYEGQYCERCAPGYTGSPGNPGGSCQECECDPYGSLPVPCDPVTGFCTCRPGATGRKCDGCKHWHAR EGWECVFCGDECTGLLLGDLARLEQMVMSINLTGPLPAPYKMLYGLENMTQELKHLLSPQRAPERLIQLAEGNLNTLVTEMNELLTRATK VTADGEQTGQDAERTNTRAKSLGEFIKELARDAEAVNEKAIKLNETLGTRDEAFERNLEGLQKEIDQMIKELRRKNLETQKEIAEDELVA AEALLKKVKKLFGESRGENEEMEKDLREKLADYKNKVDDAWDLLREATDKIREANRLFAVNQKNMTALEKKKEAVESGKRQIENTLKEGN DILDEANRLADEINSIIDYVEDIQTKLPPMSEELNDKIDDLSQEIKDRKLAEKVSQAESHAAQLNDSSAVLDGILDEAKNISFNATAAFK AYSNIKDYIDEAEKVAKEAKDLAHEATKLATGPRGLLKEDAKGCLQKSFRILNEAKKLANDVKENEDHLNGLKTRIENADARNGDLLRTL NDTLGKLSAIPNDTAAKLQAVKDKARQANDTAKDVLAQITELHQNLDGLKKNYNKLADSVAKTNAVVKDPSKNKIIADADATVKNLEQEA DRLIDKLKPIKELEDNLKKNISEIKELINQARKQANSIKVSVSSGGDCIRTYKPEIKKGSYNNIVVNVKTAVADNLLFYLGSAKFIDFLA IEMRKGKVSFLWDVGSGVGRVEYPDLTIDDSYWYRIVASRTGRNGTISVRALDGPKASIVPSTHHSTSPPGYTILDVDANAMLFVGGLTG KLKKADAVRVITFTGCMGETYFDNKPIGLWNFREKEGDCKGCTVSPQVEDSEGTIQFDGEGYALVSRPIRWYPNISTVMFKFRTFSSSAL LMYLATRDLRDFMSVELTDGHIKVSYDLGSGMASVVSNQNHNDGKWKSFTLSRIQKQANISIVDIDTNQEENIATSSSGNNFGLDLKADD KIYFGGLPTLRNLSMKARPEVNLKKYSGCLKDIEISRTPYNILSSPDYVGVTKGCSLENVYTVSFPKPGFVELSPVPIDVGTEINLSFST KNESGIILLGSGGTPAPPRRKRRQTGQAYYAILLNRGRLEVHLSTGARTMRKIVIRPEPNLFHDGREHSVHVERTRGIFTVQVDENRRYM QNLTVEQPIEVKKLFVGGAPPEFQPSPLRNIPPFEGCIWNLVINSVPMDFARPVSFKNADIGRCAHQKLREDEDGAAPAEIVIQPEPVPT PAFPTPTPVLTHGPCAAESEPALLIGSKQFGLSRNSHIAIAFDDTKVKNRLTIELEVRTEAESGLLFYMARINHADFATVQLRNGLPYFS YDLGSGDTHTMIPTKINDGQWHKIKIMRSKQEGILYVDGASNRTISPKKADILDVVGMLYVGGLPINYTTRRIGPVTYSIDGCVRNLHMA EAPADLEQPTSSFHVGTCFANAQRGTYFDGTGFAKAVGGFKVGLDLLVEFEFRTTTTTGVLLGISSQKMDGMGIEMIDEKLMFHVDNGAG RFTAVYDAGVPGHLCDGQWHKVTANKIKHRIELTVDGNQVEAQSPNPASTSADTNDPVFVGGFPDDLKQFGLTTSIPFRGCIRSLKLTKG -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for CD83-LAMA2 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for CD83-LAMA2 |
![]() (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for CD83-LAMA2 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | CD83 | C0003873 | Rheumatoid Arthritis | 1 | CTD_human |
Hgene | CD83 | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
Hgene | CD83 | C0037274 | Dermatologic disorders | 1 | CTD_human |
Hgene | CD83 | C0087031 | Juvenile-Onset Still Disease | 1 | CTD_human |
Hgene | CD83 | C0274861 | Arsenic Poisoning, Inorganic | 1 | CTD_human |
Hgene | CD83 | C0274862 | Nervous System, Organic Arsenic Poisoning | 1 | CTD_human |
Hgene | CD83 | C0311375 | Arsenic Poisoning | 1 | CTD_human |
Hgene | CD83 | C0751851 | Arsenic Encephalopathy | 1 | CTD_human |
Hgene | CD83 | C0751852 | Arsenic Induced Polyneuropathy | 1 | CTD_human |
Hgene | CD83 | C3495559 | Juvenile arthritis | 1 | CTD_human |
Hgene | CD83 | C3714758 | Juvenile psoriatic arthritis | 1 | CTD_human |
Hgene | CD83 | C4552091 | Polyarthritis, Juvenile, Rheumatoid Factor Negative | 1 | CTD_human |
Hgene | CD83 | C4704862 | Polyarthritis, Juvenile, Rheumatoid Factor Positive | 1 | CTD_human |
Tgene | C1263858 | Muscular dystrophy congenital, merosin negative | 6 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT | |
Tgene | C0026850 | Muscular Dystrophy | 2 | CTD_human | |
Tgene | C0036341 | Schizophrenia | 2 | CTD_human | |
Tgene | C4748327 | MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23 | 2 | UNIPROT | |
Tgene | C0005684 | Malignant neoplasm of urinary bladder | 1 | CTD_human | |
Tgene | C0005695 | Bladder Neoplasm | 1 | CTD_human | |
Tgene | C0027092 | Myopia | 1 | CTD_human |